| Literature DB >> 20467459 |
Magdalena Sokołowska1, Krystyna Pawlas, Wojciech Bal.
Abstract
Visible-range circular dichroism titrations were used to study Cu(II) binding properties of Multimetal Binding Site (MBS) of Human Serum Albumin (HSA). The formation of ternary MBS-Cu(II)-Buffer complexes at pH 7.4 was positively verified for sodium phosphate, Tris, and Hepes, the three most common biochemical buffers. The phosphate > Hepes > Tris order of affinities, together with strong spectral changes induced specifically by Tris, indicates the presence of both Buffer-Cu(II) and Buffer-HSA interactions. All complexes are strong enough to yield a nearly 100% ternary complex formation in 0.5 mM HSA dissolved in 100 mM solutions of respective buffers. The effects of warfarin and ibuprofen, specific ligands of hydrophobic pockets I and II in HSA on the Cu(II) binding to MBS were also investigated. The effects of ibuprofen were negligible, but warfarin diminished the MBS affinity for Cu(II) by a factor of 20, as a result of indirect conformational effects. These results indicate that metal binding properties of MBS can be modulated directly and indirectly by small molecules.Entities:
Year: 2010 PMID: 20467459 PMCID: PMC2864911 DOI: 10.1155/2010/725153
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Figure 1CD spectra of Cu(II) titration of HSA (0.5 mM in 0.1 M NaCl, pH 7.4), from 0 to 3 mol equivalents, at a 0.25 mol equivalent step.
Figure 2Titration curves (experimental points, , and fits to the K app formula, ) for Cu(II) binding at MBS in four solutions studied: (a) NaCl; (b) Hepes; (c) sodium phosphate; (d) Tris.
Figure 3Spectra of pure forms of NTS-Cu(II) complexes obtained by extrapolation of titration data.
Figure 4Spectra of pure forms of MBS-Cu(II) complexes obtained by extrapolation of titration data.
Quantitative description of ternary complexes formed by Cu(II) ions at MBS of HSA at pH 7.4. Standard deviations of significant values of experimental logarithms constants on the last digits are given in parentheses.
| Ligand (L) | log | log | log | log | log | CIe | |
|---|---|---|---|---|---|---|---|
| [L] = | 0.5 mM | 100 mM | |||||
| NaCl | 4.60(3) | 7.62 | |||||
| Hepes | 4.45(5) | 7.54(5) | 3.22 | 4.32 | −0.28 | 7.71 | 9.27 |
| Tris | 4.23(6) | 8.22(5) | 4.05 | 4.17 | −0.43 | 7.74 | 9.42 |
| Phosphate | 5.17(7) | 8.2(1) | 3.20 | 5.00 | +0.40 | 8.04 | 10.13 |
a K 111 is the equilibrium constant of the reaction Cu2+ + L + MBS = Cu(MBS)(L).
b K 11 is the equilibrium constant of the reaction Cu2+ + L = Cu(L); literature values [30–32].
c K e is the equilibrium constant of the reaction MBS + Cu(L) = Cu(MBS)(L); log K 111 = log K 11 + log K e.
d K T is the equilibrium constant of the reaction Cu(MBS) + Cu(L) = Cu(MBS)(L) + Cu2+.
log K T = log K 111 − log K 11 − log K app (NaCl).
eCI is the competitivity index (description in text), calculated for following total concentrations: Cu(II) and Z = 1 μM, HSA = 0.5 mM, buffer = 0.5 mM, or 100 mM.
Figure 5Comparison of experimental data (□), the best fit to the ternary complex model (), and the simulation of titration in the absence of ternary complex formation () for the titration of MBS in 0.1 M Hepes, pH 7.4.
Figure 6Chemical structures of warfarin (War, left) and ibuprofen (Ibu, right).
Figure 7Titrations of HSA in the presence of 1.75 mol equivalents of Cu(II) with War (A) and Ibu (B) from 0 to 2.5 mol equivalents in 0.25 mol equivalent steps. The titration of War was terminated at 2 mol equivalents due to the loss of solution transparency. The solid lines represent linear fits to the data.
Figure 8Comparison of titration curves for Cu(II) binding at MBS obtained in the presence of 1 mol equivalents of Ibu (experimental points, , and fits to the K app formula, ) and War (experimental points, , and fits to the K app formula, ).